Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Actuate Therapeutics Inc.
Psyence Australia Pty Ltd
Dana-Farber Cancer Institute
Tizona Therapeutics, Inc
Essen Biotech
Takeda
Kidney Cancer Research Bureau
Second Life Therapeutics
Novartis
UNC Lineberger Comprehensive Cancer Center
AstraZeneca
UNC Lineberger Comprehensive Cancer Center
Virginia Commonwealth University
Hadassah Medical Organization
University of Colorado, Denver
A2 Biotherapeutics Inc.
Washington University School of Medicine
Sensei Biotherapeutics, Inc.
University of California, San Francisco
Genentech, Inc.
Tampere University Hospital
ModeX Therapeutics, An OPKO Health Company
University of Alabama at Birmingham
Columbia University
Elevation Oncology
Universidade Federal de Pernambuco
Astellas Pharma Inc
Astellas Pharma Inc
Dana-Farber Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Second Affiliated Hospital of Guangzhou Medical University
Cedars-Sinai Medical Center
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Centre Georges Francois Leclerc
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Barbara Ann Karmanos Cancer Institute
Canadian Cancer Trials Group
Shanghai Yunying Medical Technology
Kineta Inc.
Quadriga Biosciences, Inc.
Ludwig Institute for Cancer Research
Imperial College London
Roswell Park Cancer Institute
Syndax Pharmaceuticals
National Institutes of Health Clinical Center (CC)
Weill Medical College of Cornell University
Novartis
Syndax Pharmaceuticals